ArticleHuman genetics2026
Genetic diversity of Usher syndrome in Moroccan patients.
Article in Human genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
Usher syndrome (USH) is a rare genetic disorder accounting for almost 50% of all hereditary deaf-blindness cases. This heterogeneous, autosomal recessive condition is categorized into 3 main clinical subtypes (USH1, USH2 and USH3) and an atypical form of USH based on the severity and age of onset of the hearing loss, the absence or presence of vestibular dysfunction and the age of retinitis pigmentosa (RP) onset. This study aims to characterize the genetic spectrum of Usher syndrome in the Moroccan population. We used targeted-exome, whole exome and Sanger sequencing to identify variants in USH genes. We identified 25 variants among which 6 novel ones with 22 variants in USH1, 3 in USH2 while none were identified in USH3. Twenty-eight out of 33 families had USH1 and 5 out of 33 had USH2. MYO7A is the most prevalent gene mutated in this study with a recurrent splice acceptor site variant c.2283-1G > T found in 7 families. Our findings contribute to the understanding of the genetic diversity of USH in the Moroccan and North African populations, and emphasize the importance of genetic screening in identifying novel variants and providing an early clinical diagnosis to establish a medical follow-up and genetic counseling.
Indexed as
Identifiers
41498812What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.